David R Buchanan

Summary

Affiliation: National Institutes of Health
Country: USA

Publications

  1. ncbi request reprint Quality-of-life assessment in the symptom management trials of the National Cancer Institute-supported Community Clinical Oncology Program
    David R Buchanan
    Division of Cancer Prevention, National Cancer Institute NIH, 6130 Executive Blvd, Room EPN 2149, Bethesda, MD 20892 7317, USA
    J Clin Oncol 23:591-8. 2005
  2. ncbi request reprint Research-design issues in cancer-symptom-management trials using complementary and alternative medicine: lessons from the National Cancer Institute Community Clinical Oncology Program experience
    David R Buchanan
    National Cancer Institute, 6130 Executive Plaza, Rm 2149, Bethesda, MD 20892 7317, USA
    J Clin Oncol 23:6682-9. 2005
  3. ncbi request reprint Perspective: a new ethic for health promotion: reflections on a philosophy of health education for the 21st century
    David R Buchanan
    Division of Cancer Prevention, National Cancer Institute, 6130 Executive Blvd, Room 2149, Bethesda, MD 20872 7317, USA
    Health Educ Behav 33:290-304. 2006
  4. ncbi request reprint Challenges and recommendations for advancing the state-of-the-science of quality of life assessment in symptom management trials
    David R Buchanan
    Community Oncology and Prevention Trials Research Group, Division of Cancer Prevention, National Cancer Institute, National Institutes of Health, Department of Health and Human Services, Bethesda, Maryland 20892, USA
    Cancer 110:1621-8. 2007
  5. pmc Justice and fairness in the Kennedy Krieger Institute lead paint study: the ethics of public health research on less expensive, less effective interventions
    David R Buchanan
    Community Health Education, 306 Arnold House, School of Public Health and Health Sciences, University of Massachusetts Amherst, Amherst, MA 01003, USA
    Am J Public Health 96:781-7. 2006

Detail Information

Publications5

  1. ncbi request reprint Quality-of-life assessment in the symptom management trials of the National Cancer Institute-supported Community Clinical Oncology Program
    David R Buchanan
    Division of Cancer Prevention, National Cancer Institute NIH, 6130 Executive Blvd, Room EPN 2149, Bethesda, MD 20892 7317, USA
    J Clin Oncol 23:591-8. 2005
    ..To examine how quality of life (QOL) is prospectively conceptualized, defined, and measured in the symptom management clinical trials supported by the National Cancer Institute Community Clinical Oncology Program (CCOP)...
  2. ncbi request reprint Research-design issues in cancer-symptom-management trials using complementary and alternative medicine: lessons from the National Cancer Institute Community Clinical Oncology Program experience
    David R Buchanan
    National Cancer Institute, 6130 Executive Plaza, Rm 2149, Bethesda, MD 20892 7317, USA
    J Clin Oncol 23:6682-9. 2005
    ..To identify major research-design issues in proposals submitted by investigators in the Community Clinical Oncology Program (CCOP) for clinical trials of complementary and alternative medicine (CAM) for cancer-symptom management...
  3. ncbi request reprint Perspective: a new ethic for health promotion: reflections on a philosophy of health education for the 21st century
    David R Buchanan
    Division of Cancer Prevention, National Cancer Institute, 6130 Executive Blvd, Room 2149, Bethesda, MD 20872 7317, USA
    Health Educ Behav 33:290-304. 2006
    ..Practitioners here use research results as a stimulus for dialogue about the role of good health habits in living the kind of life that community members find most valuable...
  4. ncbi request reprint Challenges and recommendations for advancing the state-of-the-science of quality of life assessment in symptom management trials
    David R Buchanan
    Community Oncology and Prevention Trials Research Group, Division of Cancer Prevention, National Cancer Institute, National Institutes of Health, Department of Health and Human Services, Bethesda, Maryland 20892, USA
    Cancer 110:1621-8. 2007
    ..Finally, there is a growing appreciation that trials must be powered to test for effects on secondary endpoints...
  5. pmc Justice and fairness in the Kennedy Krieger Institute lead paint study: the ethics of public health research on less expensive, less effective interventions
    David R Buchanan
    Community Health Education, 306 Arnold House, School of Public Health and Health Sciences, University of Massachusetts Amherst, Amherst, MA 01003, USA
    Am J Public Health 96:781-7. 2006
    ..We contend that the failure to conduct such research causes greater harm, because it deprives disadvantaged populations of the benefits of imminent incremental improvements in their health conditions...